Skip to main content
SpringerLink
Log in

Telmisartan

BIBR 277, Micardis®, Pritor®

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Telmisartan becomes sixth AIIRA to be registered. Marketletter 25: 20, 23 Nov 1998

  2. Van Heiningen PNM, van Lier JJ, de Bruin H, Su CAPF, Kirchgässler KU, et al. Single dose study on the pharmacodynamics and pharmacokinetics of the angiotensin II antagonist BIBR0227SE. Pharmacy World and Science 16 (Suppl D): 4, 10 Jun 1994

    Google Scholar 

  3. Ogiwara T, Azuma J, Watase T, Nagakura A, Matsumura R. A phase I clinical study of BIBR277 capsules in healthy normal subjects. Rinsho Yakuri 26: 321–322, Mar 1995

    Article  Google Scholar 

  4. Neutel JM, Smith DHG, Telmisartan US Study Group. Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Advances in Therapy 15: 206–217, Jul–Aug 1998

    CAS  Google Scholar 

  5. McClellan KJ, Markham A. Telmisartan. Drugs 56: 1039–1044, Dec 1998

    Article  PubMed  CAS  Google Scholar 

  6. Ramsay LE, Kirwan BA, Telmisartan Study Group. A comparison of cough in hypertensive patients receiving telmisartan, enalapril, or hydrochlorothiazide. Journal of Hypertension 16 (Suppl 2): 241, Jun 1998

    Google Scholar 

  7. Elliott HL. The efficacy and safety of telmisartan compared to atenolol and placebo in patients with hypertension. American Journal of Hypertension 11: 124, Part 2, Apr 1998

    Article  Google Scholar 

  8. Schelling A, Ramsay LE, Freytag F. The long term safety and efficacy of telmisartan compared to atenolol in the treatment of hypertension. Journal of Hypertension 16 (Suppl 2): 213, Jun 1998

    Google Scholar 

  9. Neutel JM. The efficacy and safety of telmisartan compared to enalapril in patientswith severe hypertension. American Journal of Hypertension 11: 111, Part 2, Apr 1998

    Google Scholar 

  10. Smith DHG, Neutel JM, Morgenstern P. Once-daily telmisartan compared with enalapril in the treatment of hypertension. Advances in Therapy 15: 229–240, Jul–Aug 1998

    CAS  Google Scholar 

  11. Neutel J, Frishman W, Oparil S, Papademitriou V, Guthrie G. A comparison of telmisartan with lisinopril in patients with mild to moderate hypertension. American Journal of Hypertension 11: 115, Part 2, Apr 1998

    Article  Google Scholar 

  12. Lacourcière Y, Telmisartan North American Study Group. A comparison of cough in hypertensive patients receiving telmisartan, lisinopril, or placebo. American Journal of Hypertension 11: 119, Part 2, Apr 1998

    Article  Google Scholar 

  13. Lefebvre J, Poirier L, Archambault F, Telmisartan North American Study Group, et al. A comparison of cough in hypertensive patients receiving telmisartan, lisinopril, or placebo. Canadian Journal of Cardiology 14 (Suppl F): 150, Sep 1998

    Google Scholar 

  14. Van Meel JCA, Hauel N, Entzeroth M, et al. Antihypertensive effects of the angiotensin receptor antagonist, BIBR 277, in conscious renal hypertensive and spontaneously hypertensive rats. British Journal of Pharmacology 108 (Suppl): 191P, Apr 1993

    Article  Google Scholar 

  15. Wienen W, Hauel N, Van Meel JCA, Narr B, Ries U, et al. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. British Journal of Pharmacology 110: 245–252, Sep 1993

    Article  PubMed  CAS  Google Scholar 

  16. Wienen W, Entzeroth M. Effects on binding characteristics and renal function of the novel, non-peptide angiotensin II antagonist BIBR 277 in the rat. Journal of Hypertension 12: 119–128, Feb 1994

    Article  PubMed  CAS  Google Scholar 

  17. Winquist R, Panzenbeck M, Madwed J, et al. The effects of BIBR277, an angiotensin II type I receptor antagonist in conscious monkeys. FASEB Journal 8: 882, Part 2, 18 Mar 1994

    Google Scholar 

  18. Izumi H, Nakai T, Kano S, Hoshi K, Ichihara K. Effects of BIBR-277, an angiotensin II type 1 receptor antagonist, on stunned myocardium in dogs. Coronary Artery Disease 7: 775–779, Oct 1996

    Article  PubMed  CAS  Google Scholar 

  19. Neutel JM, Smith DHG, Telmisartan US Study Group. Dose response and pharmacokinetics of telmisartan, a new angiotensin II receptor blocker. American Journal of Hypertension 11: 111, Part 2, Apr 1998

    Google Scholar 

  20. Lacourciere Y, Neutel JM, Smith DHG. Twenty-four hour blood pressure monitoring to compare the efficacy and duration of action of the ATII antagonist telmisartan to amlodipine. American Journal of Hypertension 10: 7, Part 2, Apr 1997

    Article  Google Scholar 

  21. Smith DHG, Neutel JM, Telmisartan US Study Group. Once daily telmisartan as compared to enalapril in the treatment of hypertension. American Journal of Hypertension 11: 111, Part 2, Apr 1998

    Article  Google Scholar 

  22. Mallion JM, Lacourcière Y, Telmisartan Blood Pressure Monitoring Group. A comparison of the blood pressure profile of telmisartan and losartan at 18–24 hours postdosing as measured by ambulatory blood pressure monitoring. American Journal of Hypertension 11: 262, Part 2, Apr 1998

    Article  Google Scholar 

  23. Karlberg BE, Lins L-E, Hermansson K, TEES Study Group. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. Journal of Hypertension 17: 293–302, Feb 1999

    Article  PubMed  CAS  Google Scholar 

  24. Mallion JM, Siche JP, Lacourcière Y, Telmisartan Blood Pressure Monitoring Group. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-tomoderate hypertension. Journal of Human Hypertension 13: 657–664, Oct 1999

    Article  PubMed  CAS  Google Scholar 

  25. McGill JB, Reilly PA. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. Clinical Therapeutics 23: 833–850, Jun 2001

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Telmisartan. Drugs R&D 3, 250–256 (2002). https://doi.org/10.2165/00126839-200203040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203040-00005

Keywords

Search

Navigation